COMPANY PROFILE · UPDATED 01 AUG 2026

Allogene Therapeutics

Allogene Therapeutics, Inc. operates as a biotechnology company. The Company develops allogeneic chimeric antigen receptor T-cell therapy for the treatment of blood cancers and solid tumors. Allogene Therapeutics serves patients in the…

allogene.com ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2017
Headcount: 261
Open roles: 0
Last raised: Post Ipo Equity · Sign in to view

LEADERSHIP

Founders & key people

OPEN ROLES

Roles at Allogene Therapeutics

Employbl doesn’t track Allogene Therapeutics’s job board yet, so there’s nothing to show here — they may still be hiring. You can also search all jobs →

FUNDING

Capital raised

Total raised

$1,092,170,409

Investors

Avoro Capital AdvisorsBellco CapitalCowen Investment ManagementDeerfield Capital ManagementFidelity InvestmentsFranklin Resources, Inc.Gilead SciencesJennison AssociatesPerceptive AdvisorsPfizerSurveyor CapitalT. Rowe PriceTPGTwo RiverVida Ventures

Funding rounds

Post Ipo Equity
$200.4MApr 14, 2026
Post Ipo Equity
$110MMay 12, 2024
Post Ipo Equity
$250MOct 31, 2019
Convertible Note
Perceptive Advisors, Deerfield Capital Management, Fidelity Investments, Jennison Associates, Franklin Resources, Inc., T. Rowe Price, Surveyor Capital, Avoro Capital Advisors, Cowen Investment Management
$120MSep 5, 2018
Series A
TPG, Vida Ventures, Pfizer, Two River, Bellco Capital, Gilead Sciences
$411.8MApr 18, 2018
IPO
UndisclosedJan 1, 2018

Funding data via Diffbot

Categorized in

Industry

Healthcare & Biotech Biotech & Drug Discovery

Industries

Medical Organizations Health Care Companies Biotechnology Companies

Tech Stack

Mysql Php Wordpress

LOCATIONS

Where they work

Allogene Therapeutics offices

Loading map…

South San Francisco, CA210 E Grand Av